370 related articles for article (PubMed ID: 24522083)
1. B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis.
De Vecchis R; Esposito C; Di Biase G; Ariano C; Giasi A; Cioppa C
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):122-34. PubMed ID: 24522083
[TBL] [Abstract][Full Text] [Related]
2. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
4. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
5. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials.
Li P; Luo Y; Chen YM
Heart Lung Circ; 2013 Oct; 22(10):852-60. PubMed ID: 23602555
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide. Guided vs. conventional care in outpatients with chronic heart failure: a retrospective study.
De Vecchis R; Esposito C; Di Biase G; Ariano C
Minerva Cardioangiol; 2013 Aug; 61(4):437-49. PubMed ID: 23846010
[TBL] [Abstract][Full Text] [Related]
8. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials.
Savarese G; Trimarco B; Dellegrottaglie S; Prastaro M; Gambardella F; Rengo G; Leosco D; Perrone-Filardi P
PLoS One; 2013; 8(3):e58287. PubMed ID: 23472172
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
Pufulete M; Maishman R; Dabner L; Higgins JPT; Rogers CA; Dayer M; MacLeod J; Purdy S; Hollingworth W; Schou M; Anguita-Sanchez M; Karlström P; Shochat MK; McDonagh T; Nightingale AK; Reeves BC
Syst Rev; 2018 Jul; 7(1):112. PubMed ID: 30064502
[TBL] [Abstract][Full Text] [Related]
11. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS
Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.
Porapakkham P; Porapakkham P; Zimmet H; Billah B; Krum H
Arch Intern Med; 2010 Mar; 170(6):507-14. PubMed ID: 20308637
[TBL] [Abstract][Full Text] [Related]
13. Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis.
Khan MS; Siddiqi TJ; Usman MS; Sreenivasan J; Fugar S; Riaz H; Murad MH; Mookadam F; Figueredo VM
Int J Cardiol; 2018 Jul; 263():80-87. PubMed ID: 29685696
[TBL] [Abstract][Full Text] [Related]
14. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptide-guided therapy: further research required for still-unresolved issues.
De Vecchis R; Esposito C; Cantatrione S
Herz; 2013 Sep; 38(6):618-28. PubMed ID: 23588602
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure.
Carubelli V; Lombardi C; Lazzarini V; Bonadei I; Castrini AI; Gorga E; Richards AM; Metra M
J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):828-39. PubMed ID: 27322401
[TBL] [Abstract][Full Text] [Related]
17. Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials.
Xin W; Lin Z; Mi S
Heart Fail Rev; 2015 Jan; 20(1):69-80. PubMed ID: 24888383
[TBL] [Abstract][Full Text] [Related]
18. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL
JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830
[TBL] [Abstract][Full Text] [Related]
19. Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?
Franke J; Frankenstein L; Schellberg D; Bajrovic A; Wolter JS; Ehlermann P; Doesch AO; Nelles M; Katus HA; Zugck C
Clin Res Cardiol; 2011 Dec; 100(12):1059-67. PubMed ID: 21779816
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M;
Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
